Russo Rene — SEC Form 4 filings
SEC reporting owner CIK 1722066. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-03 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 36,289 shares, $24,680 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: purchase of 36,289 shares @ $0.68 ($24,680) in Xilio Therapeutics, Inc., filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | PRESIDENT AND CEO, Director | 7 | 1 leg · 36,289 sh · $24,680 | — | 25 |
Form 4 filings — Russo Rene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | Xilio Therapeutics, Inc. (XLO) | Option exercise (M): 44,250 · Grant/award (A): 1,500,258 (derivative) @ $0 · Option exercise (M): 44,250 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 2,075,000 (derivative) @ $0 · Disposition to issuer (D): 239,703 (derivative) · Grant/award (A): 239,703 (derivative) · Disposition to issuer (D): 473,334 (derivative) · Grant/award (A): 473,334 (derivative) · Disposition to issuer (D): 135,134 (derivative) · +11 more | EDGAR |
| 2025-06-18 | 4/A | Xilio Therapeutics, Inc. (XLO) | Holdings only — no transactions reported | EDGAR |
| 2025-06-18 | 4 | Xilio Therapeutics, Inc. (XLO) | Purchase (P): 36,289 @ $0.68 | EDGAR |
| 2025-04-16 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Xilio Therapeutics, Inc. (XLO) | Option exercise (M): 44,250 · Option exercise (M): 44,250 (derivative) @ $0 · Grant/award (A): 638,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 474,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722066 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →